Stone Run Capital, LLC Becton Dickinson & CO Transaction History

Stone Run Capital, LLC

$269 Billion
Q3 2024

A detailed history of Stone Run Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Stone Run Capital, LLC holds 33,517 shares of BDX stock, worth $7.56 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares

33,517

Previous 27,742 20.82%

Holding current value

$7.56 Million

Previous $6.48 Billion 24.64%

% of portfolio

3.01%

Previous 2.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $1.28 Million - $1.4 Million	5,775 Added 20.82%	33,517 $8.08 Billion
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $259,055 - $283,341	1,151 Added 4.33%	27,742 $6.48 Billion
Q1 2024 May 14, 2024	SELL	$233.45 - $247.73 $1.4 Million - $1.49 Million	-5,999 Reduced 18.41%	26,591 $6.58 Billion
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $2.01 Million - $2.31 Million	8,640 Added 36.08%	32,590 $7.95 Billion
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $6.1 Million - $6.79 Million	23,950 New	23,950 $6.19 Billion
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $2.1 Million - $2.33 Million	8,790 Added 37.28%	32,370 $8.55 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $801,687 - $905,131	-3,490 Reduced 12.89%	23,580 $5.84 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $523,677 - $616,327	2,399 Added 9.72%	27,070 $6.89 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $10,154 - $52,581	-199 Reduced 0.8%	24,671 $5.5 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $2.07 Million - $2.43 Million	-8,815 Reduced 26.17%	24,870 $6.13 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $816,437 - $906,378	3,351 Added 11.05%	33,685 $8.96 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $276,326 - $301,378	1,201 Added 4.12%	30,334 $7.63 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $1.31 Million - $1.44 Million	-5,632 Reduced 16.2%	29,133 $7.16 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $697,717 - $763,485	-2,999 Reduced 7.94%	34,765 $8.45 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $51,059 - $56,513	-220 Reduced 0.58%	37,764 $9.18 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $1.61 Million - $1.78 Million	7,250 Added 23.59%	37,984 $9.51 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $278,559 - $357,297	1,291 Added 4.38%	30,734 $7.15 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $873,882 - $1.05 Million	-3,974 Reduced 11.89%	29,443 $7.04 Million
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $53,423 - $76,169	273 Added 0.82%	33,417 $7.68 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $589,942 - $665,715	2,495 Added 8.14%	33,144 $9.01 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $86,698 - $96,286	376 Added 1.24%	30,649 $7.75 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $296,751 - $335,899	-1,365 Reduced 4.31%	30,273 $7.63 Million
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $463,818 - $558,630	2,251 Added 7.66%	31,638 $7.9 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $1.81 Million - $2.28 Million	-8,852 Reduced 23.15%	29,387 $6.62 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $5,826 - $6,400	-25 Reduced 0.07%	38,239 $9.98 Million
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $790,571 - $888,396	-3,799 Reduced 9.03%	38,264 $9.17 Million
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $889,641 - $1.04 Million	4,330 Added 11.48%	42,063 $9.12 Million
Q4 2017 Feb 15, 2018	BUY	$189.0 - $222.64 $1.24 Million - $1.46 Million	6,553 Added 21.02%	37,733 $8.08 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $5.83 Million - $6.2 Million	31,180	31,180 $6.11 Million

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

251M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.

Account

Stone Run Capital, LLC Becton Dickinson & CO Transaction History